| Jeffery R Schultz, CRNA | |
|
202 Prospect Dr, Glendive, MT 59330-1943 | |
| (406) 345-3345 | |
| (406) 345-3347 |
| Full Name | Jeffery R Schultz |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 202 Prospect Dr, Glendive, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255650610 | NPI | - | NPPES |
| 1255650610 | Other | CHAMPUS (TRICARE - SOUTH REGION) | |
| 0025769 00 | Medicaid | FL | |
| G00FP | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ANT9242362 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Medical Center Specialty Physicians Llc | 2567651771 | 71 |
| Resource Anesthesiology Associates Of Mi Pc | 4082883053 | 68 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision.
BioDrain Medical, Inc., producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 as its U.S. Investor Relations representative.
A study by a group of Japanese scientists showed how a male pheromone in mice enhances sexual behaviors in females-and how it may enhance a different behavior, aggression, in males - by identifying distinct neural circuits and neurons that generate a particular behavioral response to specific chemical signals.
Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.
› Verified 3 days ago
| Entity Name | Capital Medical Center Specialty Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760785281 PECOS PAC ID: 2567651771 Enrollment ID: O20110104000592 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision.
BioDrain Medical, Inc., producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 as its U.S. Investor Relations representative.
A study by a group of Japanese scientists showed how a male pheromone in mice enhances sexual behaviors in females-and how it may enhance a different behavior, aggression, in males - by identifying distinct neural circuits and neurons that generate a particular behavioral response to specific chemical signals.
Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffery R Schultz, CRNA 202 Prospect Dr, Glendive, MT 59330-1943 Ph: (406) 345-3345 | Jeffery R Schultz, CRNA 202 Prospect Dr, Glendive, MT 59330-1943 Ph: (406) 345-3345 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision.
BioDrain Medical, Inc., producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 as its U.S. Investor Relations representative.
A study by a group of Japanese scientists showed how a male pheromone in mice enhances sexual behaviors in females-and how it may enhance a different behavior, aggression, in males - by identifying distinct neural circuits and neurons that generate a particular behavioral response to specific chemical signals.
Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.
› Verified 3 days ago
Mr. Joseph C Chamberlain, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 202 Prospect Dr, Glendive, MT 59330 Phone: 406-345-3306 | |
Shawn Patrick Regan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 202 Prospect Dr, Glendive, MT 59330 Phone: 406-345-3306 | |
Sally Reichert, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 202 Prospect Dr, Glendive, MT 59330 Phone: 406-345-3306 Fax: 406-345-3358 | |
Travis C Blackhurst, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 202 Prospect Dr, Glendive, MT 59330 Phone: 406-345-3306 |